General surgery notes
Which area of general surgery would you like notes on? · What level are these notes for?
| Sign | Description |
|---|---|
| Guarding | Involuntary reflex abdominal wall contraction |
| Rigidity | Board-like abdomen - diffuse peritonitis |
| Rebound tenderness | Pain worsens on lifting hand off abdomen |
| Referred shoulder tip pain | Diaphragmatic irritation - C5 dermatome |
"If inflammation arises under the diaphragm, shoulder tip ('phrenic') pain may be felt. This is referred pain to the C5 dermatome." - Bailey and Love's Surgery, p. 1109
| Feature | Details |
|---|---|
| Pain | Starts peri-umbilical (visceral, T10), migrates to RIF (McBurney's point) within 4-6 hours |
| Anorexia | Almost invariable |
| Nausea/vomiting | After pain onset (important - vomiting before pain suggests gastroenteritis) |
| Low-grade fever | 37.5 - 38.5°C; high fever suggests perforation |
| Constipation | Common; diarrhoea in pelvic appendix |
| Feature | Points |
|---|---|
| Migration of pain to RIF | 1 |
| Anorexia | 1 |
| Nausea/vomiting | 1 |
| Tenderness in RIF | 2 |
| Rebound tenderness | 1 |
| Elevated temperature (>37.3°C) | 1 |
| Leukocytosis (WBC >10,000) | 2 |
| Total | 9 |
Note: Modified Alvarado has only 72% sensitivity; clinical judgment by an experienced surgeon remains more accurate. - Tintinalli's Emergency Medicine
| Type | Description |
|---|---|
| Mechanical | Physical block in lumen |
| Functional/Paralytic ileus | Neuromuscular failure - no mechanical block |
| Vascular | Mesenteric ischaemia - obstruction due to loss of blood supply |
"It is essential that the hernial orifices should be carefully examined as incarceration in a hernia is one of the commonest causes of obstruction." - Pye's Surgical Handicraft, p. 9038
| Feature | Small Bowel (SBO) | Large Bowel (LBO) |
|---|---|---|
| Common causes | Adhesions, hernias | Carcinoma, diverticular disease, volvulus |
| Pain | Colicky, central/peri-umbilical | Colicky, lower abdominal |
| Vomiting | Early, profuse (bilious proximal; faeculent distal) | Late or absent |
| Distension | Moderate (central) | Marked (peripheral/flanks) |
| Constipation | Late feature | Early absolute constipation |
| X-ray | Valvulae conniventes (complete bands) | Haustral folds (incomplete) |
| Fluid loss | Up to 6 litres/day | Less |
| Patient type | Procedure |
|---|---|
| Unstable / exudative peritonitis (>24h perforation) | Simple patch closure (Graham's patch / omental patch) |
| Stable, <24h, chronic symptoms / failed medical Rx | Patch closure + Highly Selective Vagotomy (HSV) |
| Perforated gastric ulcer (stable) | Distal gastric resection (biopsy all gastric ulcers) |
| Unstable with perforated gastric ulcer | Patch closure + biopsy |
"Surgery is almost always indicated for ulcer perforation, although occasionally nonsurgical treatment can be used in the stable patient without peritonitis in whom radiologic studies document a sealed perforation." - Schwartz's Surgery 11th Ed
| Type | % | Details |
|---|---|---|
| Superior mesenteric artery (SMA) embolus | ~50% | Cardiac source (AF, MI, valvular) |
| SMA thrombosis | ~25% | Pre-existing atherosclerosis |
| Non-occlusive mesenteric ischaemia (NOMI) | ~20% | Low-flow states, vasopressors |
| Mesenteric venous thrombosis | ~5-10% | Hypercoagulable states, portal hypertension |
| Letter | Cause |
|---|---|
| G | Gallstones (most common - 40%) |
| E | Ethanol/alcohol (35%) |
| T | Trauma |
| S | Steroids |
| M | Mumps / viral |
| A | Autoimmune (IgG4) |
| S | Scorpion sting |
| H | Hyperlipidaemia / Hypercalcaemia / Hypothermia |
| E | ERCP |
| D | Drugs (azathioprine, thiazides, tetracycline) |
| Quadrant | Common Causes |
|---|---|
| RUQ | Acute cholecystitis, biliary colic, hepatitis, peptic ulcer, right lower lobe pneumonia |
| LUQ | Splenomegaly/rupture, left lower lobe pneumonia, pancreatitis, perforated gastric ulcer |
| RIF | Appendicitis, Meckel's diverticulitis, Crohn's, ovarian torsion/cyst, ectopic pregnancy, mesenteric adenitis, psoas abscess, ureteric calculus |
| LIF | Diverticulitis, sigmoid volvulus, colorectal carcinoma, ovarian pathology, ectopic |
| Epigastrium | Peptic ulcer/perforation, acute pancreatitis, MI (inferior) |
| Generalised | Diffuse peritonitis, early appendicitis, mesenteric ischaemia |
| Topic | High-Yield Fact |
|---|---|
| Appendicitis | Pain migrates peri-umbilical → RIF; Alvarado score max = 9 |
| Peritonitis | Patient lies still; vomiting before pain = gastroenteritis |
| SBO causes | Adhesions > hernias > tumour |
| LBO causes | Carcinoma > diverticular disease > volvulus |
| Strangulation | Suspect with tachycardia, fever, constant pain, tenderness |
| Perforated ulcer | Free gas under diaphragm on erect CXR; Graham's patch repair |
| Mesenteric ischaemia | Pain out of proportion to signs; CT angiography; mortality ~50-80% |
| Pancreatitis | Gallstones + alcohol = 75%; Glasgow score >3 = severe |
| Shoulder tip pain | Diaphragmatic irritation - C5 dermatome |
| Always do | PR exam + examine hernial orifices in all acute abdomen |
Basics of surgery for 2nd year
| Type | Also Called | When It Occurs |
|---|---|---|
| Primary intention | First intention | Clean wound, edges approximated within 12-24h (surgical incision, clean laceration) |
| Secondary intention | Second intention | Large/infected wound left open; heals by granulation tissue from base upward |
| Tertiary intention | Delayed primary closure | Wound left open initially (contaminated), then closed after 4-5 days once clean |
"Healing by first intention is characterized by closure of a wound within 12-24 hours of its formation. These wounds are clean and well perfused... Wound edges are approximated using sutures, skin glue, steri-strips or other mechanical devices." - Scott-Brown's Otorhinolaryngology
| Time | Tensile Strength |
|---|---|
| Day 0-3 | Nil (fibrin clot only) |
| Week 1-2 | ~5-10% |
| 3 weeks | ~20% |
| 6 weeks | ~50% |
| 3-6 months | ~80% (maximum) |
| Condition | Description |
|---|---|
| Hypertrophic scar | Raised scar, stays within wound boundaries; regresses over time; treat with silicone, compression, steroids |
| Keloid | Grows beyond wound boundaries; does NOT regress; more common in darker skin, presternal/deltoid/earlobe; treat with excision + adjuvant radiotherapy (high recurrence) |
| Wound dehiscence | Reopening of wound; risk factors: infection, poor nutrition, obesity, steroids |
| Incisional hernia | Late complication of wound; abdominal wall defect under intact skin |
| Chronic wound | Fails to progress through normal healing phases; e.g., venous ulcer, diabetic foot ulcer, pressure sore |
"Shock is a systemic state of low tissue perfusion that is inadequate for normal cellular respiration." - Bailey & Love's Surgery, p. 634
| System | Response |
|---|---|
| Cardiovascular | Baroreceptor activation → ↑sympathetic tone → tachycardia + vasoconstriction |
| Respiratory | ↑ Respiratory rate → compensatory respiratory alkalosis |
| Renal | ↓ GFR → ↓ urine output; RAAS activated → Na + water retention, further vasoconstriction |
| Endocrine | ADH release → water retention; cortisol + glucagon → hyperglycaemia |
| Class | Blood Loss | HR | BP | RR | Urine Output | Consciousness |
|---|---|---|---|---|---|---|
| I | <750 mL (<15%) | <100 | Normal | 14-20 | >30 mL/h | Normal |
| II | 750-1500 mL (15-30%) | 100-120 | Normal | 20-30 | 20-30 mL/h | Anxious |
| III | 1500-2000 mL (30-40%) | 120-140 | Decreased | 30-40 | 5-15 mL/h | Confused |
| IV | >2000 mL (>40%) | >140 | Very low | >35 | Negligible | Lethargic/unconscious |
| Type | HR | BP | CO | SVR | JVP |
|---|---|---|---|---|---|
| Hypovolaemic | ↑ | ↓ | ↓ | ↑ | ↓ |
| Cardiogenic | ↑ | ↓ | ↓ | ↑ | ↑ |
| Obstructive | ↑ | ↓ | ↓ | ↑ | ↑ |
| Distributive (septic) | ↑ | ↓ | ↑ (early) | ↓ | ↓ |
| Compartment | % Body Weight | Volume (70 kg adult) |
|---|---|---|
| Total Body Water (TBW) | 60% | ~42 L |
| Intracellular fluid (ICF) | 40% | ~28 L |
| Extracellular fluid (ECF) | 20% | ~14 L |
| - Interstitial | 15% | ~10.5 L |
| - Intravascular (plasma) | 5% | ~3.5 L |
| Fluid | Contents | Osmolality | Distribution | Use |
|---|---|---|---|---|
| 0.9% NaCl (Normal saline) | Na⁺ 154, Cl⁻ 154 mmol/L | 308 mOsm/L | ECF only | Resuscitation, hyponatraemia |
| Hartmann's / Ringer's lactate | Na 131, K 5, Ca 2, Cl 111, lactate 29 mmol/L | 278 mOsm/L | ECF only | Preferred resuscitation fluid (more physiological) |
| 5% Dextrose | 50g/L glucose | 278 mOsm/L | Distributes to all compartments | Maintenance, hypoglycaemia |
| Colloids (e.g., Gelatin) | Large molecules | - | Stays intravascular | Temporary volume expansion |
| Blood (PRBC) | - | - | Intravascular | Haemorrhage, severe anaemia |
| Class | Description | Infection Risk |
|---|---|---|
| Clean | Elective, no hollow organ entered (e.g., thyroidectomy, hernia repair) | 1-2% |
| Clean-contaminated | Hollow organ entered under controlled conditions (e.g., cholecystectomy, colonic resection with bowel prep) | 3-5% |
| Contaminated | Acute inflammation without pus; major breach of asepsis (e.g., fresh GI spillage, traumatic wound <4h) | 10-15% |
| Dirty/Infected | Established infection, faecal soiling, perforated viscus (e.g., perforated appendix, faecal peritonitis) | >30% |
| Test | Pathway Tested | Normal Value |
|---|---|---|
| PT (Prothrombin Time) | Extrinsic + common | 11-13 seconds |
| INR | Standardised PT ratio | 0.8-1.2 |
| APTT | Intrinsic + common | 25-35 seconds |
| Thrombin Time (TT) | Final common | 10-15 seconds |
| Platelet count | Primary haemostasis | 150-400 × 10⁹/L |
| Bleeding time | Platelet function | 2-7 minutes |
| Drug | Mechanism | Monitoring | Reversal |
|---|---|---|---|
| Heparin (UFH) | Activates antithrombin III (↑ AT-III activity) | APTT | Protamine sulphate |
| LMWH (enoxaparin, dalteparin) | Anti-Xa >> anti-IIa | Anti-Xa level | Partial reversal with protamine |
| Warfarin | Inhibits Vit K-dependent factors (II, VII, IX, X, Protein C&S) | INR | Vit K; FFP (emergency); 4-factor PCC (urgent) |
| DOACs (rivaroxaban, apixaban) | Direct factor Xa inhibition | No routine test | Andexanet alfa (specific) / PCC |
| Dabigatran | Direct thrombin (IIa) inhibitor | TT, ECT | Idarucizumab (specific) |
| Product | Contents | 1 Unit raises... | Indication |
|---|---|---|---|
| Packed Red Blood Cells (PRBC) | Red cells, Hb ~270 g/unit | Hb by ~1 g/dL | Anaemia, acute blood loss |
| Fresh Frozen Plasma (FFP) | All clotting factors | - | Coagulopathy, warfarin reversal |
| Platelets | Platelet concentrate | Platelets by ~30 × 10⁹/L | Thrombocytopenia, platelet dysfunction |
| Cryoprecipitate | Fibrinogen, vWF, Factor VIII, XIII | Fibrinogen by ~1 g/L | DIC, haemophilia A, vWD |
| Complication | Notes |
|---|---|
| Febrile non-haemolytic reaction | Most common; leukocyte antibodies; treat with paracetamol, slow transfusion |
| Acute haemolytic reaction | ABO incompatibility; STOP transfusion, IV fluids, check sample; life-threatening |
| Allergic/anaphylactic | Plasma protein antibodies; antihistamine/adrenaline |
| TRALI (Transfusion-Related Acute Lung Injury) | Non-cardiogenic pulmonary oedema within 6h; supportive |
| TACO (Transfusion-Associated Circulatory Overload) | Pulmonary oedema in fluid-sensitive patients; treat with diuretics |
| Infection (viral/bacterial) | Rare with modern screening |
| Massive transfusion complications | Hypocalcaemia (citrate chelates Ca²⁺), hypothermia, dilutional coagulopathy, hyperkalaemia |
| Test | Indication |
|---|---|
| FBC | All major surgery |
| U&E | Major surgery, renal disease, diuretics |
| LFT | Liver disease, jaundice, alcohol history |
| Coagulation (PT, APTT) | Bleeding disorder, anticoagulants, liver disease |
| Blood glucose/HbA1c | Diabetes |
| ECG | Age >40, cardiac history |
| CXR | Cardiac/respiratory disease, major surgery |
| Group & Save / Crossmatch | Expected blood loss |
| Echo, stress test | Significant cardiac history |
| Grade | Description | Example |
|---|---|---|
| I | Healthy patient | Young fit adult |
| II | Mild systemic disease | Controlled DM, mild HTN |
| III | Severe systemic disease | Poorly controlled DM, COPD, stable angina |
| IV | Severe, constant threat to life | Recent MI, severe COPD, liver failure |
| V | Moribund, not expected to survive 24h | Ruptured AAA |
| VI | Brain-dead organ donor | - |
| E suffix | Emergency surgery | e.g., IIE, IIIE |
| Time | Complication |
|---|---|
| Immediate (0-24h) | Primary haemorrhage, airway obstruction, anaphylaxis, MI, arrhythmia |
| Early (1-3 days) | Reactionary haemorrhage (vasodilation), atelectasis, aspiration pneumonia, UTI, paralytic ileus, hypotension |
| Delayed (>3 days) | DVT/PE, secondary haemorrhage (infection eroding vessel), wound infection, anastomotic leak (day 5-7), SIADH, chest infection |
| Late (weeks-months) | Incisional hernia, adhesional obstruction, keloid, port-site hernia |
| Route | Indication | Notes |
|---|---|---|
| Oral | First choice if gut functioning | Encourage early post-op eating |
| Enteral (NGT/NJT) | Gut functioning but unable to eat | "If the gut works, use it" |
| Total Parenteral Nutrition (TPN) | Non-functional gut: ileus, short bowel, high-output fistula, severe IBD | Via central venous catheter; expensive; high complication rate |
| Type | Origin | Features |
|---|---|---|
| Benign | Any tissue | Well-differentiated, encapsulated, no metastasis, local pressure effects |
| Malignant | Any tissue | Poorly differentiated, invasive, metastasises, anaplastic features |
| Carcinoma | Epithelium | Most common in adults |
| Sarcoma | Connective tissue / mesenchyme | Bone, muscle, fat, vessels |
| Lymphoma | Lymphoid tissue | |
| Teratoma | Germ cells |
| Marker | Tumour |
|---|---|
| CEA | Colorectal cancer (monitoring recurrence) |
| CA 19-9 | Pancreatic cancer |
| CA 125 | Ovarian cancer |
| AFP | Hepatocellular carcinoma, testicular (non-seminoma) |
| PSA | Prostate cancer |
| β-hCG | Choriocarcinoma, testicular (seminoma + non-seminoma) |
| Topic | Key Fact |
|---|---|
| Wound healing phases | Haemostasis → Inflammation → Proliferation → Remodelling |
| "Master cell" of wound healing | Macrophage |
| Max tensile strength of healed wound | ~80% of original skin |
| Keloid vs hypertrophic scar | Keloid extends beyond wound borders; does not regress |
| Shock definition | Inadequate tissue perfusion for cellular respiration |
| Class III haemorrhagic shock | 30-40% blood loss; BP drops; confused patient |
| Most common cause of surgical shock | Hypovolaemia |
| Distributive shock features | Warm, vasodilated (early); high CO; low SVR |
| Surgical wound classes | Clean → Clean-contaminated → Contaminated → Dirty |
| Antibiotic prophylaxis timing | 30-60 min before incision; single dose |
| TPN complication to know | Refeeding syndrome (hypophosphataemia) |
| Enteral over parenteral advantage | Maintains gut mucosa, prevents bacterial translocation |
| Most common post-op complication | Atelectasis (day 1-2) |
| PE peak timing post-op | Day 5-10 |
| DVT prophylaxis | LMWH + TED stockings + early mobilisation |
| Malignant tumour spread (carcinoma) | Lymphatic most common |
| Von Willebrand factor role | Bridges platelet GPIb to subendothelial collagen |
What are preoperative checups
| System | Key Conditions to Ask About |
|---|---|
| Cardiovascular | Hypertension, IHD/angina, previous MI, arrhythmia, heart failure, valvular disease, pacemaker |
| Respiratory | Asthma, COPD, OSA (obstructive sleep apnoea), recent URTI |
| Endocrine | Diabetes mellitus, thyroid disease, adrenal disease |
| Renal | Chronic kidney disease, dialysis |
| Hepatic | Cirrhosis, hepatitis, jaundice |
| Haematological | Bleeding disorders, anaemia, DVT/PE, clotting disorders |
| Neurological | Epilepsy, stroke, Parkinson's disease |
| Drug Category | Perioperative Action |
|---|---|
| Anticoagulants (warfarin) | Stop 5 days before; bridge with LMWH if high clot risk |
| DOACs (rivaroxaban, apixaban, dabigatran) | Stop 24-48h before (longer if renal impairment) |
| Antiplatelet agents (aspirin, clopidogrel) | Usually continue aspirin; stop clopidogrel 5-7 days before elective surgery |
| Antihypertensives (ACE inhibitors/ARBs) | Omit morning dose on day of surgery (risk of intraop hypotension) |
| Beta-blockers | Continue (stopping risks rebound hypertension/tachycardia) |
| Metformin | Omit on day of surgery and 48h post-op (risk of lactic acidosis) |
| Oral hypoglycaemics | Omit on day of surgery |
| Insulin | Reduce dose or sliding scale |
| Steroids | Continue; may need "steroid cover" (hydrocortisone 25-50 mg IV) if long-term steroids |
| NSAIDs | Stop 1 week before (bleeding and renal risk) |
| OCP/HRT | Stop 4 weeks before major surgery (VTE risk) |
| MAOIs | Stop 2 weeks before (dangerous interactions with anaesthetics) |
| What | Minimum Fast Before Surgery |
|---|---|
| Solid food | 6 hours |
| Breast milk | 4 hours |
| Clear fluids (water, black tea/coffee) | 2 hours |
For emergency surgery, always ask "When did you last eat/drink?" - full stomach = aspiration risk → rapid sequence induction (RSI) needed
| Grade | View on mouth opening (tongue out, no phonation) | Difficulty |
|---|---|---|
| I | Full view of soft palate, uvula, fauces, pillars | Easy |
| II | Soft palate, uvula, fauces visible | Easy |
| III | Soft palate, base of uvula only | Difficult |
| IV | Only hard palate visible | Very difficult |
| Test | When to Order |
|---|---|
| FBC (Full Blood Count) | All major surgery; anaemia, thrombocytopenia screening |
| U&E (Urea & Electrolytes) | Major surgery, renal disease, patients on diuretics/ACE inhibitors, diabetes |
| LFTs (Liver Function Tests) | Hepatic disease, alcohol history, jaundice, medications affecting liver |
| Coagulation (PT, APTT, INR) | Bleeding disorder history, anticoagulants, liver disease, major vascular/cardiac surgery |
| Blood glucose / HbA1c | Known or suspected diabetes |
| Urea & Creatinine (eGFR) | Renal disease, elderly, NSAIDs, ACE inhibitor use |
| Thyroid function (TFTs) | Thyroid disease, goitre, amiodarone use |
| Serum albumin | Malnutrition screening, major surgery |
| Group & Screen (G&S) | Moderate blood loss expected |
| Crossmatch | Significant blood loss expected (e.g., major vascular, colorectal, liver surgery) |
| Sickle cell test | African/Afro-Caribbean patients (if not previously done) |
| Pregnancy test (βhCG) | All women of reproductive age (MANDATORY before elective surgery) |
| Test | Indication |
|---|---|
| ECG (12-lead) | Age >40, known/suspected cardiac disease, hypertension, diabetes |
| Echocardiogram | Known/suspected valvular disease, heart failure, murmur, poor exercise tolerance |
| Stress ECG / Exercise tolerance test | Suspected ischaemic heart disease |
| Coronary angiogram / CTCA | High cardiac risk + planned major surgery |
| Cardiopulmonary exercise testing (CPET) | High-risk patients before major surgery - assesses functional reserve objectively |
| Test | Indication |
|---|---|
| CXR (Chest X-ray) | Cardiac/respiratory disease, suspected lung pathology, major thoracic surgery |
| Spirometry (PFTs) | Asthma, COPD - to quantify severity and guide optimisation |
| ABG (Arterial Blood Gas) | Severe respiratory disease, baseline hypoxia, thoracic surgery |
| Sleep study | Suspected obstructive sleep apnoea (important for anaesthesia - CPAP may be needed post-op) |
| Test | Indication |
|---|---|
| Urinalysis / MSSU | Urinary symptoms, diabetes, renal disease (detect UTI before surgery) |
| HIV / Hepatitis B & C serology | High-risk patients, or where it affects surgical technique |
| Clotting studies (TEG/ROTEM) | Major surgery with expected significant haemorrhage |
| Grade | Description | Mortality Risk | Example |
|---|---|---|---|
| ASA I | Normal healthy patient | 0.1% | Young adult with no disease |
| ASA II | Mild systemic disease, no functional limitation | 0.2% | Controlled HTN, mild DM, BMI 30-40, smoker |
| ASA III | Severe systemic disease, functional limitation | 1.8% | Poorly controlled DM, COPD, morbid obesity, angina, CKD 3 |
| ASA IV | Severe systemic disease, constant threat to life | 7.8% | Recent MI (<3 months), severe heart failure, liver failure |
| ASA V | Moribund, not expected to survive 24h without operation | 9.4% | Ruptured AAA, massive PE |
| ASA VI | Brain-dead, organ donation | - | - |
| "E" suffix | Emergency surgery | Higher in each class | e.g., ASA IIE |
| Condition | Optimisation Required |
|---|---|
| Hypertension | BP should be <160/100 before elective surgery |
| Diabetes | HbA1c ideally <69 mmol/mol (8.5%); control glucose perioperatively |
| Anaemia | Treat cause; iron supplementation (oral 6-8 weeks before; IV iron if urgent); transfuse if Hb <8 g/dL before major surgery |
| Cardiac | Optimise heart failure; consider cardiology input if recent MI/unstable angina (delay elective surgery ≥6 weeks after MI) |
| Respiratory | Physiotherapy; bronchodilators; treat infection; stop smoking |
| Obesity | Weight loss programme; CPAP if OSA |
| Malnutrition | Nutritional support for 7-14 days pre-op (enteral preferred) |
| Anticoagulants | Bridge therapy as needed |
| Renal failure | Dialysis scheduling; correct electrolytes |
| Measure | Details |
|---|---|
| TED stockings | All patients unless contraindicated (peripheral vascular disease) |
| Intermittent pneumatic compression (IPC) | Used intraoperatively and post-op |
| LMWH (e.g., enoxaparin 40mg SC daily) | Start evening before or 6-12h post-op; continue until mobile |
| Duration | 28 days for major pelvic/abdominal cancer surgery; 10 days for other major surgery |
| Stage | When | Key Checks |
|---|---|---|
| Sign In | Before anaesthesia induction | Identity, site, consent, allergies, airway risk, blood loss risk |
| Time Out | Before skin incision | Confirm team, procedure, site, antibiotics given, imaging displayed |
| Sign Out | Before patient leaves theatre | Procedure confirmed, specimen labelled, instrument/swab count correct, post-op plan |
HISTORY → PMH, drugs, allergies, anaesthetic history, social history, fasting
EXAMINATION → Airway, CVS, respiratory, weight/BMI, relevant system
INVESTIGATIONS → Bloods (FBC, U&E, coag, G&S), ECG, CXR, spirometry
RISK SCORING → ASA grade, cardiac risk index, METs, DVT risk
OPTIMISATION → Control BP/DM, treat anaemia, stop/adjust drugs
CONSENT → Informed, voluntary, capacity
PROPHYLAXIS → Antibiotics, DVT (LMWH + stockings)
DAY OF SURGERY → WHO checklist, site marking, confirm fasting, IV access
Preoperative checkup and preparation are required for major abdominal surgery under general anesthesia in an obese and asthmical patient
| Risk Factor | Surgical Complication Risk Raised |
|---|---|
| Obesity (BMI >30) | Difficult airway, aspiration, DVT/PE, wound infection, respiratory failure, OSA |
| Asthma | Bronchospasm on intubation, intraoperative wheeze, post-op atelectasis, respiratory failure |
| General anaesthesia | Airway manipulation triggers bronchospasm; obese patients desaturate rapidly on induction |
| Major abdominal surgery | High diaphragmatic splinting post-op → atelectasis; prolonged procedure |
| Drug | Action Before Surgery |
|---|---|
| Salbutamol (SABA) inhaler | Continue; give a dose 2 hours before induction |
| ICS (budesonide, beclomethasone) | Continue; do NOT stop |
| LABA (salmeterol, formoterol) | Continue |
| Oral corticosteroids | Continue + add stress dose steroids (see below) |
| Theophylline | Continue with caution; check levels |
| Metformin | Omit on day of surgery and 48h post-op |
| Antihypertensives (ACE-i/ARBs) | Omit morning dose on day of surgery |
| Beta-blockers (non-selective) | Avoid or use with caution - can provoke bronchospasm in asthmatics; if on for cardiac reason, use cardioselective (bisoprolol, metoprolol) |
| NSAIDs / Aspirin | AVOID in aspirin-sensitive asthmatics (Samter's triad: asthma + nasal polyps + aspirin sensitivity) |
| Anticoagulants | Stop/bridge as appropriate |
"The incidence of difficult intubation in obese patients was three times the incidence compared to the non-obese population." - Miller's Anaesthesia 10th Ed
| Assessment | Finding in Obese Patients | Clinical Significance |
|---|---|---|
| Mallampati score (I-IV) | Often III or IV due to large tongue, soft tissue | Score III/IV = difficult laryngoscopy |
| Thyromental distance | Often reduced by fat | <6 cm = difficult intubation |
| Neck circumference | >40 cm = risk factor | Predicts difficult intubation |
| Mouth opening | May be limited | <3 cm = difficult |
| Neck mobility | Assess flexion/extension | Reduced = difficult positioning |
| Pretracheal soft tissue | Increased in obese | Ultrasound assessment useful |
"Obese patients should be readily intubated by direct laryngoscopy if placed carefully in ramped position... Video laryngoscopy provides better glottic view and decreased intubation time in obese patients." - Miller's Anaesthesia 10th Ed
| Test | Rationale in This Patient |
|---|---|
| FBC | Anaemia (raises respiratory risk); baseline WBC |
| U&E / Creatinine | Renal function (obesity → glomerulosclerosis; steroid use) |
| LFTs | NAFLD/NASH very common in obese (abnormal ALT in up to 1/3) |
| Blood glucose + HbA1c | Type 2 DM common in obese (25× increase in DM risk per BMI unit above 22) |
| Lipid profile | Dyslipidaemia part of metabolic syndrome screening |
| TFTs (thyroid function) | ~25% of morbidly obese have subclinical hypothyroidism |
| Coagulation (PT, APTT, INR) | Baseline; liver disease in obese affects coagulation |
| Serum albumin | Nutritional status; important for wound healing |
| Group & Screen / Crossmatch | Major abdominal surgery - blood loss expected |
| Pregnancy test (βhCG) | Women of reproductive age - mandatory |
| Test | Indication | Finding in Asthma |
|---|---|---|
| Spirometry (PFTs) | Confirm and grade asthma severity; baseline before GA | Obstructive pattern: FEV₁/FVC <0.7; FEV₁ reduced |
| Peak Flow Rate | Simple bedside; compare with personal best | Reduced in active asthma |
| CXR | Baseline; rule out pneumonia, hyperinflation, pneumothorax, cardiomegaly | Hyperinflation in severe asthma |
| ABG (Arterial Blood Gas) | If SpO₂ <94% on air; severe/difficult-to-control asthma | pCO₂ raised = severe/Type 2 respiratory failure |
| FENO (Exhaled NO) | Assess airway inflammation; guides steroid optimisation | Raised in eosinophilic asthma |
| Test | Indication |
|---|---|
| 12-lead ECG | Obese patients (hypertension, IHD risk); look for LVH, arrhythmia, ischaemia |
| Echocardiogram | If clinically indicated: heart failure, murmur, raised JVP, OSA (cor pulmonale) |
| Stress ECG / CPET | If poor exercise tolerance (<4 METs) - assess cardiac reserve before major surgery |
| Feature | ASA Grade Implication |
|---|---|
| Morbid obesity alone | ASA III |
| Obesity + moderate-severe asthma | ASA III minimum |
| Obesity + poorly controlled asthma + other comorbidities (DM, HTN) | ASA III-IV |
"Preoperative treatment with combined corticosteroids and an inhaled β₂-adrenergic agonist for a 5-day period may decrease the risk of postoperative bronchospasm in patients with asthma." - Berek & Novak's Gynaecology
| Issue | Action |
|---|---|
| Weight reduction | Pre-op weight loss (even modest amounts improve respiratory mechanics, GORD, DM) |
| OSA | Initiate/continue CPAP; ensure CPAP device comes to hospital |
| GORD / reflux | Start PPI (omeprazole 20-40 mg OD) 1 week before surgery; reduces aspiration severity |
| Diabetes | Target HbA1c <69 mmol/mol (8.5%); perioperative insulin sliding scale |
| Hypertension | Target BP <160/100 before surgery |
| NAFLD/NASH | Check LFTs; if cirrhosis present → Child-Pugh score to assess liver risk |
| Anaemia | Treat iron deficiency with IV iron if time-limited |
| Physiotherapy | Pre-operative inspiratory muscle training (IMT); teaches breathing exercises → reduces post-op atelectasis |
| Drug | Dosing Based On |
|---|---|
| Propofol (induction) | Lean Body Weight (LBW) |
| Succinylcholine (suxamethonium) | Total Body Weight (TBW) |
| Non-depolarising NMBA (rocuronium, vecuronium) | LBW |
| Opioids (fentanyl, morphine) | LBW (avoid overdose → respiratory depression) |
| Antibiotics | Higher doses needed; TBW-based |
| Issue | Plan |
|---|---|
| Respiratory monitoring | SpO₂ continuous monitoring; high-dependency or HDU bed post-op |
| CPAP continuation | Restart CPAP as soon as possible post-extubation (if OSA) |
| Asthma medications | Resume inhalers as soon as awake (nebulised salbutamol if unable to use inhaler initially) |
| Steroid cover | Hydrocortisone 25mg IV 8-hourly × 24h, then taper to usual dose |
| Analgesia | Multimodal (paracetamol + NSAIDs - CAUTION in aspirin-sensitive asthmatic → avoid NSAIDs; use paracetamol + opioid-sparing regional technique + PCA opioid) |
| Physiotherapy | Early chest physio from post-op day 1; incentive spirometry; deep breathing exercises |
| DVT prophylaxis | Continue LMWH (28 days for major abdominal surgery); TED stockings + early mobilisation |
| Fluid management | Careful fluid balance (avoid overload → pulmonary oedema in obese) |
| Nutritional support | Early enteral feeding (ERAS protocol - oral fluids same day or next morning) |
| Early mobilisation | Sitting out of bed Day 1; ambulation Day 1-2 (reduces atelectasis + VTE) |
| HDU/ICU criteria | Admit to HDU if: post-op bronchospasm, difficult extubation, severe OSA, BMI >50, prolonged surgery |
HISTORY
✓ Asthma: severity, control, medications, triggers, previous bronchospasm under GA
✓ Obesity: BMI, OSA (STOP-BANG), GORD, DM, HTN, exercise tolerance
✓ Drugs: steroids, inhalers, antihypertensives, metformin, anticoagulants
✓ Allergies: aspirin/NSAIDs (AERD), latex, antibiotics
EXAMINATION
✓ BMI, neck circumference, weight distribution
✓ AIRWAY: Mallampati, thyromental distance, mouth opening, neck mobility
✓ Chest: wheeze, SpO₂, air entry
✓ CVS: BP, JVP, oedema
✓ Abdomen: NAFLD, varices
INVESTIGATIONS
✓ Bloods: FBC, U&E, LFT, glucose/HbA1c, coag, TFTs, albumin, G&S
✓ Spirometry: FEV₁, FVC, peak flow
✓ CXR, ECG
✓ ABG if SpO₂ <94% or severe asthma
✓ Sleep study if STOP-BANG ≥3
✓ Echo if suspected cardiac disease
OPTIMISATION
✓ Asthma: 5-day pre-op ICS + SABA course; oral prednisolone if poorly controlled
✓ SABA 2 puffs 2h before induction
✓ CPAP for OSA
✓ PPI for GORD
✓ DM: HbA1c <8.5%, sliding scale
✓ BP: <160/100
✓ Stop smoking ≥8 weeks pre-op
✓ Pre-op physiotherapy / IMT
DAY OF SURGERY
✓ Fasting: 6h solids, 2h fluids
✓ Continue inhalers; steroid stress cover if indicated
✓ Antibiotics: higher dose for obese 30-60 min before incision
✓ DVT: TED stockings + IPC + LMWH
✓ Antacid + anti-emetic
✓ WHO checklist, site marking, consent
POST-OP
✓ HDU monitoring
✓ Resume CPAP; restart inhalers
✓ Multimodal analgesia (avoid NSAIDs if aspirin-sensitive)
✓ Early physio + mobilisation
✓ LMWH 28 days
Shorten these notes to 4 pages
| Risk Factor | Key Danger |
|---|---|
| Obesity | Difficult airway, aspiration, DVT/PE, wound infection, OSA, rapid O₂ desaturation |
| Asthma | Bronchospasm on intubation, intraop wheeze, post-op atelectasis |
| GA + major abdominal surgery | Airway manipulation triggers bronchospasm; diaphragmatic splinting post-op |
| Drug | Action |
|---|---|
| Salbutamol / ICS / LABA | Continue; give SABA 2 puffs 2h before induction |
| Oral corticosteroids | Continue + add steroid stress cover |
| Non-selective beta-blockers | Avoid (bronchospasm risk); switch to cardioselective |
| NSAIDs / aspirin | Avoid in aspirin-sensitive asthmatics |
| Metformin | Omit day of surgery + 48h post-op |
| ACE inhibitors / ARBs | Omit morning dose on day of surgery |
| Anticoagulants | Stop/bridge as appropriate |
| Assessment | Risk Sign |
|---|---|
| Mallampati score | Grade III/IV |
| Thyromental distance | <6 cm |
| Neck circumference | >40 cm |
| Mouth opening | <3 cm |
| Neck mobility | Reduced |
| Test | Rationale |
|---|---|
| FBC | Anaemia raises respiratory risk |
| U&E / Creatinine | Renal function (obesity, steroid use) |
| LFTs | NAFLD/NASH in up to 1/3 of obese patients |
| Blood glucose + HbA1c | Type 2 DM very common in obese |
| TFTs | ~25% morbidly obese have subclinical hypothyroidism |
| Coagulation | Baseline; liver disease affects clotting |
| Serum albumin | Nutritional status, wound healing |
| Group & Screen / Crossmatch | Major abdominal surgery |
| Pregnancy test | Women of reproductive age - mandatory |
| Test | Purpose |
|---|---|
| Spirometry | Confirm severity; FEV₁ ideally >80% predicted before surgery |
| Peak flow | Compare to personal best |
| CXR | Baseline; hyperinflation, cardiomegaly, infection |
| ABG | If SpO₂ <94% or severe/difficult asthma |
| Test | Indication |
|---|---|
| 12-lead ECG | All obese patients (HTN, IHD risk); LVH, ischaemia |
| Echo | Heart failure, murmur, raised JVP, cor pulmonale (OSA) |
| CPET | Poor exercise tolerance (<4 METs) before major surgery |
| Tool | This Patient |
|---|---|
| ASA grade | Minimum ASA III (obesity + asthma); ASA IV if poorly controlled + DM + HTN |
| RCRI | Major abdominal surgery = high-risk; add obesity-related cardiac risk |
| VTE risk | High (obesity + major surgery) → extended prophylaxis 28 days |
| Respiratory risk (ARISCAT) | High (abdominal surgery + asthma + obesity + >2h operative time) |
| Problem | Action |
|---|---|
| OSA | Initiate/continue CPAP; bring to hospital |
| GORD | PPI (omeprazole 40 mg OD) 1 week pre-op; sodium citrate on day of surgery |
| Diabetes | HbA1c <8.5%; perioperative insulin sliding scale |
| Hypertension | BP <160/100 before elective surgery |
| Smoking | Stop ≥8 weeks before (minimum 1-2 weeks reduces sputum) |
| Pre-op physio | Inspiratory muscle training (IMT); deep breathing exercises → reduces atelectasis |
| Anaemia | IV iron if time-limited; transfuse if Hb <8 g/dL |
| Step | Detail |
|---|---|
| Fasting | 6h solids; 2h clear fluids |
| Inhalers | Continue ICS/LABA as normal; salbutamol 2 puffs 2h before induction |
| Steroid cover | Hydrocortisone IV at induction if indicated |
| Antacid | Sodium citrate 30 mL oral + PPI/H₂ blocker → aspiration protection |
| Antibiotic prophylaxis | IV 30-60 min before incision; higher dose in obese (e.g., cefazolin 3g if BMI >40) |
| DVT prophylaxis | TED stockings + IPC devices on legs; LMWH evening before or 12h post-op |
| Anti-emetics | Prescribed pre-op (ondansetron ± dexamethasone) |
| IV access | May be difficult in obese - use ultrasound guidance |
| Consent | Specifically document: difficult airway risk, bronchospasm risk, VTE risk, wound infection, HDU care |
| WHO Checklist | Sign In → Time Out → Sign Out; site marking confirmed |
| Drug | Based On |
|---|---|
| Propofol, opioids, NMBA | Lean Body Weight |
| Succinylcholine, antibiotics | Total Body Weight |
| Issue | Plan |
|---|---|
| Monitoring | HDU/high-dependency bed; continuous SpO₂ |
| CPAP | Restart as soon as awake post-extubation |
| Asthma | Resume inhalers; nebulised salbutamol initially if unable to use inhaler |
| Steroid taper | Hydrocortisone 25 mg IV 8-hourly × 24h → oral dose |
| Analgesia | Multimodal: paracetamol + regional (TAP block/epidural) + PCA opioid; avoid NSAIDs in aspirin-sensitive asthmatic |
| Physio | Chest physio day 1; incentive spirometry; deep breathing |
| DVT | LMWH × 28 days; TED stockings; early mobilisation |
| Nutrition | Early enteral feeding (same day / day 1 - ERAS) |
| HDU criteria | Admit if: bronchospasm, difficult extubation, BMI >50, severe OSA, prolonged surgery |
HISTORY → Asthma control, OSA (STOP-BANG), GORD, DM, HTN, drugs, allergies
EXAM → Airway (Mallampati, neck, thyromental), SpO₂, wheeze, BP, BMI
BLOODS → FBC, U&E, LFT, glucose/HbA1c, TFTs, coag, albumin, G&S
RESP → Spirometry (FEV₁>80%), CXR, ABG if severe, sleep study if OSA
CARDIAC → ECG, echo if indicated, CPET if poor exercise tolerance
OPTIMISE → 5-day ICS+SABA, prednisolone if poor control, CPAP, PPI,
BP/DM control, stop smoking, pre-op physiotherapy
DAY OF OP → Salbutamol 2 puffs 2h before, steroid cover, antacid,
higher-dose antibiotics, TED+IPC+LMWH, WHO checklist
POST-OP → HDU, CPAP, inhalers, multimodal analgesia, early physio + mobilise
Of abdominal surgery
What specifically about abdominal surgery would you like notes on?
"The goal of an efficacious incision is to provide adequate exposure to perform the procedure with minimal perturbation of the abdominal wall function." - Schwartz's Surgery 11th Ed
| Category | Examples | Advantages | Disadvantages |
|---|---|---|---|
| Longitudinal | Midline, paramedian | Wide access, extensible, fast | Higher incisional hernia risk (some data) |
| Transverse / Oblique | Kocher, Pfannenstiel, McBurney/Grid-iron, Lanz | Better cosmesis, possibly lower hernia rate (some data) | More limited access, risk of nerve injury |
"There does not appear to be differences in early or late postoperative complications or recovery time between these two types of incisions. However, transverse incisions may be associated with lower incisional hernia rates but higher rates of wound infections." - Schwartz's Surgery 11th Ed
| Incision | Position | Muscle Handling | Main Uses |
|---|---|---|---|
| Midline | Along linea alba (xiphi-pubic) | None cut (avascular) | Emergency laparotomy, bowel surgery, aorta, all abdominal organs |
| Paramedian | 2-3 cm lateral to midline, vertical | Rectus retracted (not cut) | Ipsilateral abdominal organs (largely obsolete) |
| Kocher (subcostal) | 2 cm below costal margin, oblique | Rectus cut | Cholecystectomy (open), liver, biliary, spleen |
| Bilateral Kocher (Chevron) | Both subcostal + midline | Rectus cut bilateral | Liver transplant, total gastrectomy, Whipple's |
| Grid-iron (McBurney's) | RIF oblique at McBurney's pt | Muscles split (not cut) | Open appendicectomy |
| Lanz | RIF transverse at McBurney's level | Muscles split | Open appendicectomy (better cosmesis) |
| Pfannenstiel | 2 cm above pubis, transverse | Rectus separated in midline | Hysterectomy, C-section, bladder, pelvic surgery |
| Rutherford-Morrison | Extended Pfannenstiel to iliac fossa | Oblique muscle-splitting | Renal transplant |
| Thoracoabdominal | Thorax + abdomen combined | Diaphragm divided | Oesophageal, OGJ, liver surgery |
| Category | Common Operations | Usual Incision/Approach |
|---|---|---|
| Stomach | Gastrectomy (total/partial), Heller myotomy, gastric bypass | Upper midline / Kocher / laparoscopic |
| Small bowel | Small bowel resection, strictureplasty, adhesiolysis | Midline / laparoscopic |
| Large bowel | Right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, abdominoperineal resection (APR) | Midline / laparoscopic |
| Appendix | Appendicectomy | Grid-iron / Lanz / laparoscopic |
| Liver | Hepatectomy (right/left), segmentectomy | Right Kocher / bilateral Kocher |
| Gallbladder | Cholecystectomy (open/laparoscopic) | Kocher (open) / laparoscopic (ports) |
| Pancreas | Whipple's (pancreaticoduodenectomy), distal pancreatectomy | Bilateral Kocher / midline |
| Spleen | Splenectomy | Left Kocher / midline / laparoscopic |
| Aorta | AAA repair, aorto-bifemoral bypass | Midline |
| Uterus/ovaries | Hysterectomy, ovarian cystectomy | Pfannenstiel / laparoscopic |
| Bladder/prostate | Cystectomy, prostatectomy | Pfannenstiel / midline / laparoscopic/robotic |
| Kidney | Nephrectomy, pyeloplasty | Loin / laparoscopic |
| Hernia | Inguinal, umbilical, incisional repair | Inguinal / midline / laparoscopic (TEP/TAPP) |
| Complication | Notes |
|---|---|
| Haematoma / Seroma | Blood or fluid in wound; often minor; aspirate if large |
| Wound infection (SSI) | Days 4-7; open wound + antibiotics |
| Burst abdomen (Dehiscence) | Fascial disruption; pink "salmon-coloured" fluid from wound; emergency re-suture |
| Incisional hernia | Late complication; fascial defect under intact skin; repair with mesh |
| Nerve injury | Denervation of rectus → bulge/hernia; pain from neuroma |
| Keloid / Hypertrophic scar | Abnormal healing |
| Incision | Mnemonic / Key Fact |
|---|---|
| Midline | Avascular, fastest, most versatile, emergency go-to |
| Kocher | "Koch" = chol → Cholecystectomy; parallel to costal margin |
| Grid-iron | McBurney's point; muscles SPLIT not cut; for appendix |
| Lanz | Transverse at same point as grid-iron; better cosmesis |
| Pfannenstiel | "Bikini line"; pelvic surgery; beautiful scar |
| Chevron | Both Kochers together; liver transplant; "rooftop" |
| Midline closure | Loop PDS continuous; suture-to-wound ratio ≥4:1 |
| Laparoscopy entry | Hasson (safe/open) vs. Veress needle (blind/closed) |
| CO₂ pressure | 10-15 mmHg ideal; >25 mmHg = dangerous |
| Linea alba | Fusion of all three flat muscle aponeuroses; avascular |
Preoperative checkup and preparation are required for major abdominal surgery under general anesthesia in an obese
| Problem | Consequence |
|---|---|
| Excess neck/pharyngeal soft tissue | Difficult airway, difficult intubation |
| Reduced FRC, low lung compliance | Rapid O₂ desaturation on induction |
| High intra-abdominal pressure + reflux | ↑ Aspiration risk |
| OSA | Post-op hypoxaemia, respiratory arrest |
| Metabolic syndrome (DM, HTN, dyslipidaemia) | Cardiac complications, poor wound healing |
| NAFLD/NASH | Impaired drug metabolism, coagulopathy |
| Immobility + venous stasis | High DVT/PE risk |
| Thick abdominal wall | Wound infection, dehiscence, incisional hernia |
| Letter | Question |
|---|---|
| S | Snoring loudly? |
| T | Tired/sleepy during the day? |
| O | Observed to stop breathing during sleep? |
| P | Pressure (hypertension diagnosed)? |
| B | BMI >35? |
| A | Age >50? |
| N | Neck circumference >40 cm? |
| G | Gender = male? |
| Drug | Perioperative Action |
|---|---|
| Metformin | Omit day of surgery + 48h post-op (lactic acidosis risk) |
| Oral hypoglycaemics (sulphonylureas) | Omit on day of surgery (hypoglycaemia risk) |
| Insulin | Reduce dose; start sliding scale peri-operatively |
| ACE inhibitors / ARBs | Omit morning dose on day of surgery (intraop hypotension) |
| Antihypertensives (beta-blockers, CCBs) | Continue |
| OCP / HRT | Stop 4 weeks before major surgery (VTE risk) |
| Anticoagulants | Stop/bridge as appropriate |
| Test | Abnormal Finding | Significance |
|---|---|---|
| Mallampati grade | III or IV | Difficult laryngoscopy (3× more likely vs. non-obese) |
| Thyromental distance | <6 cm | Difficult intubation |
| Mouth opening | <3 cm (2 fingers) | Difficult intubation |
| Neck mobility | Reduced | Cannot achieve sniffing position |
| Neck circumference | >40 cm | Independent predictor of difficult intubation |
| Pretracheal soft tissue (ultrasound) | Increased | Best predictor in obese patients |
Plan: Ramped position (ear-to-sternal notch); Video laryngoscopy; Difficult airway trolley available
| Test | Rationale in Obese Patient |
|---|---|
| FBC | Anaemia (raises periop risk); polycythaemia (chronic hypoxia from OSA) |
| U&E / Creatinine / eGFR | Renal function (obesity → glomerulosclerosis; ACE inhibitors; DM) |
| LFTs | NAFLD/NASH in up to 1/3 of obese patients; abnormal ALT most common |
| Blood glucose + HbA1c | Type 2 DM (risk ↑ 25% per 1 kg/m² rise in BMI above 22) |
| Lipid profile | Dyslipidaemia (part of metabolic syndrome) |
| TFTs | ~25% of morbidly obese have subclinical hypothyroidism |
| Coagulation (PT, APTT, INR) | Liver disease (NAFLD/NASH affects clotting factors) |
| Serum albumin | Nutritional status; wound healing predictor |
| Group & Screen / Crossmatch | Major abdominal surgery - expected blood loss |
| Pregnancy test (βhCG) | All women of reproductive age - mandatory |
| Test | Indication |
|---|---|
| 12-lead ECG | All obese patients - LVH, ischaemia, arrhythmia, right heart strain |
| Echocardiogram | Heart failure, murmur, raised JVP, suspected pulmonary hypertension (OSA → cor pulmonale) |
| Stress ECG / Exercise test | Suspected IHD, poor exercise tolerance |
| CPET (Cardiopulmonary Exercise Test) | Objective functional capacity assessment before major surgery if <4 METs on history |
| Test | Indication |
|---|---|
| CXR | Baseline; cardiomegaly, pulmonary oedema, pleural effusion, infection |
| Spirometry | If COPD suspected or significant dyspnoea; not routine for obesity alone |
| ABG | If SpO₂ <94% on air or suspected Type 2 respiratory failure (obesity hypoventilation syndrome) |
| Polysomnography (Sleep Study) | STOP-BANG ≥3 → confirm OSA; guides CPAP initiation |
| Test | Purpose |
|---|---|
| Abdominal USS | Screen for NAFLD, gallstones (3× more common in obese), hernia |
| Fasting insulin / HOMA-IR | Insulin resistance assessment if DM not yet diagnosed |
| Obesity Scenario | ASA Grade |
|---|---|
| Obese (BMI 30-39) - no other comorbidities | ASA II |
| Obese + controlled DM/HTN | ASA III |
| Morbidly obese + poorly controlled DM + IHD + OSA | ASA III-IV |
| Step | Detail |
|---|---|
| Fasting | 6h solids; 2h clear fluids (same as non-obese) |
| CPAP | Continue until transfer to theatre; restart immediately post-op |
| Antacid prophylaxis | Sodium citrate 30 mL oral + PPI/H₂ blocker → reduce aspiration risk |
| Antibiotic prophylaxis | Single IV dose 30-60 min before incision; HIGHER DOSE in obese: cefazolin 3g if BMI >40 (standard 2g under-doses in obesity) |
| DVT prophylaxis | TED stockings + IPC (intermittent pneumatic compression) devices on both legs |
| LMWH | Enoxaparin - give evening before or 12h post-op; higher dose in morbidly obese (e.g., 40mg BD if BMI >40) |
| Anti-emetics | Prescribe prophylactically (ondansetron ± dexamethasone) |
| Blood glucose check | Capillary glucose on arrival; start insulin sliding scale if DM |
| IV access | May be difficult - use ultrasound guidance; large-bore (16G minimum) |
| Consent | Document specific risks: difficult airway, aspiration, post-op HDU admission, wound infection, DVT/PE, respiratory complications |
| Site marking | Surgeon marks operative site |
| WHO Safety Checklist | Sign In → Time Out → Sign Out |
| Drug | Dose Based On | Why |
|---|---|---|
| Propofol (induction) | Lean Body Weight (LBW) | Mainly distributes to lean tissue |
| Succinylcholine (suxamethonium) | Total Body Weight (TBW) | Pseudocholinesterase activity increases with obesity |
| Rocuronium / vecuronium | LBW | Avoid prolonged neuromuscular blockade |
| Fentanyl / morphine | LBW | Avoid respiratory depression post-op |
| Antibiotics (cefazolin) | TBW | Under-dosing = inadequate prophylaxis |
| LMWH (enoxaparin) | Weight-based (higher dose) | Standard dose inadequate in obesity |
LBW formula (males): 50 + 0.9 × (height in cm - 152) LBW formula (females): 45 + 0.9 × (height in cm - 152)
| Issue | Plan |
|---|---|
| Monitoring level | HDU or high-dependency bed - continuous SpO₂, ECG, BP |
| CPAP | Restart as soon as awake and extubated |
| Oxygen | Supplemental O₂ post-op; wean slowly; maintain SpO₂ >94% |
| Analgesia | Multimodal (reduces opioids = less respiratory depression): paracetamol + regional (TAP block / epidural / wound infiltration) + PCA opioid if needed |
| Avoid | High-dose systemic opioids alone (respiratory depression, OSA) |
| DVT prophylaxis | LMWH 28 days after major abdominal surgery; TED stockings; IPC; early mobilisation Day 1 |
| Physiotherapy | Chest physio from Day 1; incentive spirometry; deep breathing; early ambulation |
| Fluid balance | Careful monitoring - avoid overload (pulmonary oedema risk) |
| Blood glucose | Monitor 1-2 hourly; insulin sliding scale; target 6-10 mmol/L |
| Nutrition | Early enteral feeding - oral fluids same day or Day 1 (ERAS); avoid prolonged fasting |
| Wound care | Inspect daily; larger dressings may be needed; negative pressure wound therapy (NPWT) if high infection risk |
| HDU admission criteria | Morbid obesity (BMI >40), OSA on CPAP, difficult extubation, intraop complications, prolonged surgery >4h |
HISTORY
✓ BMI, OSA (STOP-BANG ≥3?), GORD, DM, HTN, IHD, exercise tolerance (<4 METs?)
✓ Drugs: metformin, insulin, ACE-i, OCP - adjust accordingly
EXAMINATION
✓ Airway: Mallampati, neck circumference, thyromental distance, mouth opening
✓ SpO₂ on air, BP both arms, JVP, oedema, hepatomegaly
INVESTIGATIONS
✓ Bloods: FBC, U&E, LFT, glucose/HbA1c, TFTs, coag, albumin, G&S/XM
✓ ECG (all obese), CXR, Echo if indicated
✓ ABG if SpO₂ <94%
✓ Sleep study if STOP-BANG ≥3
OPTIMISE
✓ Initiate CPAP for OSA
✓ PPI for GORD
✓ HbA1c <8.5%, BP <160/100, treat anaemia
✓ Stop smoking ≥8 weeks
✓ Pre-op physiotherapy (IMT)
✓ Weight loss if time allows
DAY OF SURGERY
✓ Fasting: 6h solids, 2h fluids
✓ Antacid (sodium citrate + PPI)
✓ Antibiotics: higher dose (cefazolin 3g if BMI >40)
✓ DVT: TED stockings + IPC + LMWH (weight-adjusted)
✓ IV access (USS-guided if difficult)
✓ Consent, site marking, WHO checklist
ANAESTHESIA
✓ Ramped position + video laryngoscope
✓ RSI with cricoid pressure
✓ Lung-protective ventilation (6-8 mL/kg IBW + PEEP)
✓ Drug doses based on LBW (except suxamethonium + antibiotics = TBW)
POST-OP
✓ HDU, CPAP restart, O₂ monitoring
✓ Multimodal analgesia (minimise opioids)
✓ LMWH 28 days, early mobilisation Day 1
✓ Blood glucose control, early feeding, chest physio
Stages of pregnancy changes that occur in various systems during pregnancy
| Stage | Weeks | Key Changes Occurring |
|---|---|---|
| 1st Trimester | 0-12 | Hormonal surge (hCG, progesterone, oestrogen); early cardiovascular and renal changes begin |
| 2nd Trimester | 13-26 | Maximum vasodilation (BP lowest); uterus enlarges; mechanical effects begin |
| 3rd Trimester | 27-40 | Uterine pressure effects peak; FRC falls; cardiac output rises further during labour |
| Labour & Delivery | Term | CO increases 60-80% further; haemodynamic changes maximum |
| Postpartum | Weeks 1-2 | Most changes resolve; blood volume normalises by 1-2 weeks; some effects persist 6 months |
| Parameter | Change | Magnitude |
|---|---|---|
| Cardiac output | ↑ | +40% at term |
| Plasma volume | ↑ | +55% |
| Blood volume (total) | ↑ | +35% (1000-1500 mL extra) |
| Heart rate | ↑ | +20% (10-15 bpm) |
| Stroke volume | ↑ | +30% |
| Systolic BP | ↓ | -5% (returns to normal by 3rd trimester) |
| Diastolic BP | ↓ | -15% (lowest at mid-2nd trimester) |
| SVR (peripheral resistance) | ↓ | -15% |
| Pulmonary resistance | ↓ | -30% |
| Oxygen consumption | ↑ | +20-50% |
| Minute ventilation | ↑ | +50% |
| Tidal volume | ↑ | +40% |
| Respiratory rate | ↑ | +15% |
| FRC | ↓ | -20% |
| PaCO₂ | ↓ | -15% (28-32 mmHg) |
| PaO₂ | ↑ | +10% |
| HCO₃⁻ | ↓ | -15% (compensatory) |
| GFR | ↑ | +50% |
| Haemoglobin | ↓ | -20% (dilutional) |
| Platelets | ↓ | -10% (3rd trimester) |
| Clotting factors | ↑ | +30-250% (hypercoagulable) |
| MAC (anaesthetic requirement) | ↓ | -40% at term |
| Parameter | Change | Detail |
|---|---|---|
| Plasma volume | ↑ 55% | Begins week 6; greatest expansion |
| RBC mass | ↑ 45% | Increases less than plasma → dilutional anaemia |
| Total blood volume | ↑ 35% (1000-1500 mL extra) | Allows tolerance of delivery blood loss |
| Cardiac output | ↑ 40% at term | Due to ↑ HR (20%) + ↑ SV (30%) |
| Heart rate | ↑ 10-15 bpm | Begins 1st trimester |
| Stroke volume | ↑ 30% | Cardiac chambers enlarge; LV hypertrophy on echo |
| BP | Slight fall mid-pregnancy, returns to normal at term | DBP falls more than SBP |
| SVR | ↓ 15-20% | Progesterone-mediated vasodilation |
| CVP / PCWP | Unchanged | Despite increased blood volume |
| Pulmonary resistance | ↓ 30% | Prevents pulmonary hypertension |
| Parameter | Change | Clinical Significance |
|---|---|---|
| Tidal volume (VT) | ↑ 40% | Main driver of ↑ minute ventilation |
| Respiratory rate | ↑ 15% | Contributes less than VT |
| Minute ventilation | ↑ 50% | Maintains lower PaCO₂ for fetal CO₂ diffusion |
| Oxygen consumption | ↑ 20-50% | Increased metabolic demands |
| FRC | ↓ 20% | Reduced O₂ reserve; rapid desaturation during apnoea |
| Vital capacity | Minimally changed | Not significantly affected |
| Closing capacity | Unchanged but may exceed FRC in supine | Atelectasis + hypoxaemia in supine position |
| Airway resistance | ↓ 35% | Progesterone → bronchodilation |
| PaCO₂ | ↓ to 28-32 mmHg | Normal in pregnancy; important - not a sign of hyperventilation pathology |
| PaO₂ | ↑ slightly | Hyperventilation increases alveolar O₂ |
| HCO₃⁻ | ↓ to ~20 mmol/L | Renal compensation for respiratory alkalosis |
| P50 (O₂-Hb dissociation) | ↑ from 27→30 mmHg | ↑ 2,3-DPG → Hb releases O₂ more readily to tissues |
| Component | Change | Detail |
|---|---|---|
| Plasma volume | ↑ 55% | Largest expansion; driven by RAAS activation + oestrogen |
| RBC mass | ↑ 45% | Smaller proportional rise than plasma |
| Haemoglobin | ↓ ~20% (dilutional anaemia) | Normal Hb in pregnancy: >11 g/dL (WHO) |
| Haematocrit | ↓ (dilutional) | Normal in pregnancy: 33-38% |
| WBC | ↑ (up to 15,000/µL; up to 21,000 in labour) | Physiological leukocytosis - do NOT mistake for infection |
| Platelets | ↓ 10% in 3rd trimester | Gestational thrombocytopenia - usually mild and benign |
| Fibrinogen | ↑ 50% | Rises from ~3 to 4-6 g/L |
| Factors VII, VIII, IX, X, XII | ↑ 30-250% | Hypercoagulable state |
| Factor XI | ↓ slightly | Exception to the hypercoagulable trend |
| Protein C, S | ↓ | Acquired resistance to activated Protein C |
| Fibrinolysis | ↓ | ↑ PAI-1 and PAI-2 (placenta) → reduced clot breakdown |
| Parameter | Change | Clinical Significance |
|---|---|---|
| Renal plasma flow | ↑ 70-80% by 2nd trimester | Driven by ↑ CO + renal vasodilation |
| GFR | ↑ 50% | Begins 1st trimester; peaks at 2nd trimester |
| Serum creatinine | ↓ (as low as 0.5 mg/dL = 44 µmol/L) | Normal adult value may be abnormal in pregnancy |
| Blood urea nitrogen (BUN) | ↓ (as low as 9 mg/dL) | Dilutional + hyperfiltration |
| Plasma osmolality | ↓ 8-10 mOsm/kg | Reset of osmotic threshold for ADH |
| Glucosuria | Present (1-10 g/day) | Reduced renal threshold for glucose - NORMAL; not necessarily diabetes |
| Proteinuria | Mild (<300 mg/day) | Normal; >300 mg/day = pathological (preeclampsia) |
| Hydronephrosis / Hydroureter | Present (esp. right side) | Mechanical compression by uterus + progesterone relaxing ureteral smooth muscle |
| Sodium retention | ↑ | RAAS activated; oestrogen promotes Na reabsorption |
| Water retention | ↑ | Contributes to physiological oedema |
| Change | Detail | Clinical Significance |
|---|---|---|
| Gastric motility | ↓ (progesterone relaxes smooth muscle) | Delayed gastric emptying → prolonged aspiration risk |
| Lower oesophageal sphincter (LOS) pressure | ↓ (progesterone effect) | GORD, regurgitation, oesophagitis very common |
| Stomach displacement | Upward + anteriorly (by uterus) | Further impairs LOS competence |
| Gastric acid | Unchanged | But aspiration is still dangerous due to volume + reduced LOS tone |
| Gastroesophageal reflux | Very common | Affects 40-85% of pregnant women |
| Gallbladder motility | ↓ (progesterone inhibits CCK release) | Incomplete emptying → bile stasis → cholesterol gallstone formation |
| Transaminases (ALT, AST) | Mild ↑ (3rd trimester) | Usually not significant |
| Alkaline phosphatase | ↑ | Secreted by placenta - NORMAL; do not assume liver/bone disease |
| Serum albumin | ↓ (dilutional) | ↓ colloid oncotic pressure → physiological oedema |
| Pseudocholinesterase | ↓ 25-30% | Rarely significant for suxamethonium dosing; returns to normal 6 weeks postpartum |
| Intestinal motility | ↓ | Constipation very common |
| Nausea / vomiting | 1st trimester (hCG-driven) | Hyperemesis gravidarum if severe |
| Change | Detail |
|---|---|
| Hepatic blood flow | Unchanged overall |
| Transaminases (ALT, AST) | Mild ↑ in 3rd trimester (can be normal) |
| Alkaline phosphatase | ↑ (placental secretion) |
| Albumin | ↓ (dilutional) |
| Clotting factors | ↑ (see Haematological) |
| Cholesterol | ↑ |
| Gallstones | ↑ risk (incomplete gallbladder emptying + altered bile composition) |
| Pseudocholinesterase | ↓ 25-30% (rarely clinical significance) |
| Spider naevi + palmar erythema | Normal in pregnancy (oestrogen effect) - not liver disease |
| Hormone | Change | Function During Pregnancy |
|---|---|---|
| hCG (Human Chorionic Gonadotropin) | ↑ rapidly in 1st trimester; peaks week 10-12; then falls | Maintains corpus luteum → progesterone production early; causes morning sickness |
| Progesterone | ↑ progressively (up to 20× normal at term) | Uterine quiescence; smooth muscle relaxation (GI, ureter, vascular); stimulates respiration; sedating |
| Oestrogen | ↑ progressively | Vascular changes; mucosal growth; stimulates SHBG, TBG, clotting factors |
| hPL (Human Placental Lactogen) | ↑ throughout | Insulin resistance; lipolysis; ensures fetal glucose supply; prepares breasts for lactation |
| Cortisol | ↑ (↑ CBG binding + ↑ free cortisol) | Fetal lung maturation; contributes to insulin resistance |
| Aldosterone | ↑ | Sodium and water retention; contributes to plasma volume expansion |
| ADH (vasopressin) | Reset to lower osmolality threshold | Contributes to water retention |
| Prolactin | ↑ progressively | Prepares breasts for lactation |
| Relaxin | ↑ | Softens pubic symphysis, cervix; ligament laxity throughout body |
| Change | Detail | Clinical Significance |
|---|---|---|
| MAC (minimum alveolar concentration) | ↓ 40% at term | Pregnant patients need less general anaesthetic agent; risk of overdose if not adjusted |
| Progesterone (sedating) | ↑ 20× at term | Contributes to ↓ MAC; also reduces anxiety |
| β-endorphins | ↑ during labour | Natural analgesia; contributes to ↓ MAC |
| Local anaesthetic sensitivity | ↑ (reduced requirements) | Epidural dose reduced by up to 30%; hormonally mediated |
| Epidural venous plexus | Engorged (IVC compression) | ↓ CSF volume; ↓ epidural space volume; ↑ cephalad spread of spinal/epidural block |
| Epidural pressure | Positive (instead of usual negative) | Unusual finding; bearing down accentuates this |
| Change | Detail |
|---|---|
| Relaxin (ligament softening) | All ligaments become lax throughout body |
| Pubic symphysis | Widens (relaxin effect) → pelvic girdle pain |
| Lumbar lordosis | Increases to compensate for anterior shift in centre of gravity |
| Sacroiliac joints | More mobile |
| Joint laxity | General ↑ throughout; ↑ injury risk |
| Calcium and phosphate | Redistributed to support fetal skeleton |
| Bone mass | Minor ↓ (calcium transferred to fetus) |
| Change | Cause |
|---|---|
| Hyperpigmentation (melasma, linea nigra) | ↑ MSH (melanocyte-stimulating hormone) |
| Spider naevi + palmar erythema | ↑ Oestrogen (vascular changes) |
| Striae gravidarum | Mechanical stretching + corticosteroid effects |
| Breast enlargement + tenderness | Oestrogen + progesterone + prolactin |
| Colostrum production | Prolactin (from ~16 weeks) |
| Increased sweating | ↑ Metabolic rate + vasodilation |
| Hair changes | ↑ Anagen phase during pregnancy → post-partum telogen effluvium (hair loss 2-3 months after delivery) |
| Parameter | Change |
|---|---|
| Cardiac output | ↑ further 60-80% above pre-labour levels |
| BP | ↑ with each uterine contraction |
| O₂ consumption | ↑ further (muscle work of uterus) |
| Pain/anxiety | ↑ catecholamines → ↑ HR, BP |
| Autotransfusion | 300-500 mL with each uterine contraction (compression of uterine vessels) |
| Post-delivery | Sudden ↑ in venous return (uterus contracts + IVC decompressed) → risk of acute pulmonary oedema in cardiac patients |
| System | Most Important Change | Clinical Implication |
|---|---|---|
| CVS | CO ↑ 40%; plasma volume ↑ 55% | Dilutional anaemia; supine hypotension |
| Respiratory | FRC ↓ 20%; MV ↑ 50% | Rapid desaturation; PaCO₂ 28-32 = normal |
| Airway | Mucosal oedema and engorgement | Smaller ETT; gentle laryngoscopy |
| Haematology | Hypercoagulable; dilutional anaemia | DVT/PE risk; iron + folate supplements |
| Renal | GFR ↑ 50%; creatinine ↓ | Normal creatinine is LOW in pregnancy |
| GIT | ↓ LOS pressure; ↓ gastric motility | Aspiration risk → RSI for GA |
| Liver | ↑ ALP (placental), ↓ albumin | ALP elevation is normal in pregnancy |
| Endocrine | Insulin resistance; ↑ cortisol | Gestational DM; glucose monitoring |
| CNS | MAC ↓ 40%; epidural spread ↑ | Reduce anaesthetic doses |
| MSK | Ligament laxity (relaxin) | Pelvic girdle pain; injury risk |
| Thyroid | Total T3/T4 ↑, but FREE normal | Do not treat elevated total T4 in pregnancy |